A case study of lean drug discovery: from project driven research to innovation studios and process factories.
At the operational level, the number of investigational new drugs or candidates for development per dollar spent in research, and the number of patents per year are highly integrated measures of productivity and, thus, difficult to influence at the individual or lab level. Hence, different metrics are needed to assess and thereby improve productivity in research at the individual and group level. This review centers on a case study, including over 70 interviews, in a research department of a global pharmaceutical company as well as over 40 interviews in contract research organizations (CROs) and 5 in small biotechnology firms. For each lab, its value adding process was plotted according to lean six sigma methods and appropriate metrics were defined. We suggest a strong focus on short feedback loops in research as an indicator for efficiency. Our results reveal two categories of activities: creativity-driven ones and process-driven ones, both discussed with respect to the methodology used. The fundamental differences in nature of these activities require different sets of metrics to assess them. On the basis of these metrics, different organizational forms can be derived to achieve a lean research structure: innovation studios and process factories, respectively.
Ullman
Fredrik
F
ETH Zurich, D-MTEC, Chair of Technology and Innovation Management, Kreuzplatz 5, 8032 Zurich, Switzerland. fullman@ethz.ch
Boutellier
Roman
R
D003625:Data Collection; D015195:Drug Design; D004345:Drug Industry / Q000458:organization & administration*; D015507:Drugs, Investigational; D017598:Efficiency, Organizational / Q000639:trends; D006801:Humans; D012107:Research Design / Q000639:trends*
D015507:Drugs, Investigational